In the last trading session, 1.03 million shares of the AnaptysBio Inc (NASDAQ:ANAB) were traded, and its beta was -0.20. Most recently the company’s share price was $24.25, and it changed around $0.8 or 3.41% from the last close, which brings the market valuation of the company to $712.47M. ANAB currently trades at a discount to its 52-week high of $41.31, offering almost -70.35% off that amount. The share price’s 52-week low was $12.21, which indicates that the current value has risen by an impressive 49.65% since then. We note from AnaptysBio Inc’s average daily trading volume that its 10-day average is 0.51 million shares, with the 3-month average coming to 631.44K.
AnaptysBio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.33. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 3 recommended ANAB as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight.
AnaptysBio Inc (NASDAQ:ANAB) trade information
Instantly ANAB has showed a green trend with a performance of 3.41% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 24.73 on recent trading dayincreased the stock’s daily price by 1.94%. The company’s shares are currently down -2.61% year-to-date, but still up 9.23% over the last five days. On the other hand, AnaptysBio Inc (NASDAQ:ANAB) is 14.71% up in the 30-day period. We can see from the shorts that 9.15 million shares have been sold at a short interest cover period of 12.72 day(s).
The consensus price target as assigned by Wall Street analysts is $39.5, which translates to bulls needing to increase their stock price by 38.61% from its current value. Analyst projections state that ANAB is forecast to be at a low of $25 and a high of $54.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -7.30%. AnaptysBio Inc earnings are expected to increase by -2.88% in 2025, but the outlook is negative -2.22% per year for the next five years.
ANAB Dividends
AnaptysBio Inc’s next quarterly earnings report is expected to be released on 2025-May-05.
AnaptysBio Inc (NASDAQ:ANAB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.10% of AnaptysBio Inc shares, and 134.20% of them are in the hands of institutional investors. The stock currently has a share float of 141.42%. AnaptysBio Inc stock is held by 212.0 institutions, with ECOR1 CAPITAL, LLC being the largest institutional investor. By 2024-06-30, it held 27.4931% of the shares, which is about 7.52 million shares worth $188.48 million.
FMR LLC, with 10.4936% or 2.87 million shares worth $71.94 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and T. Rowe Price New Horizons Fund, Inc. were the top two Mutual Funds as of Mar 31, 2025 . The former held 668.95 shares worth $16.22 million, making up 2.28% of all outstanding shares. On the other hand, T. Rowe Price New Horizons Fund, Inc. held roughly 545.28 shares worth around $13.22 million, which represents about 1.86% of the total shares outstanding.
